| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/07/1996 | WO1996006616A1 Quinazolinone pharmaceuticals and use thereof |
| 03/07/1996 | WO1996006615A1 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 03/07/1996 | CA2198908A1 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 03/07/1996 | CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 03/07/1996 | CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound |
| 03/07/1996 | CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 03/07/1996 | CA2198097A1 Spirostanyl glycosidal crystals |
| 03/07/1996 | CA2198080A1 Cell cycle regulated repressor and dna element |
| 03/06/1996 | EP0699679A1 Tetrahydropyranyl compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/06/1996 | EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists |
| 03/06/1996 | EP0699666A1 Heterocyclic substituted benzoylguanidine |
| 03/06/1996 | EP0699665A1 Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists |
| 03/06/1996 | EP0699663A1 Alkyl-benzoylguanidine derivatives |
| 03/06/1996 | EP0699660A2 Arylbenzoylguanidines |
| 03/06/1996 | EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/06/1996 | EP0699437A1 Pharmaceutical preparations containing polyunsaturated fatty acids, their esters or salts, together with antioxidant vitamins or provitamins |
| 03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 03/06/1996 | EP0699194A1 5-ht4 receptor antagonists |
| 03/06/1996 | EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/06/1996 | EP0699187A1 DERIVATIVES OF -g(b), -g(b)-DIMETHYL-4-PIPERIDINEETHANAMINE AS INHIBITORS OF THE CHOLESTEROL BIOSYNTHESIS |
| 03/06/1996 | EP0699185A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
| 03/06/1996 | EP0699182A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs |
| 03/06/1996 | EP0699075A1 Modified factor vii |
| 03/06/1996 | EP0699072A1 Iron-binding polymers for oral administration |
| 03/06/1996 | EP0699070A1 Aurintricarboxylic acid fractions and analogues with anti-angiogenic activity and methods of use |
| 03/06/1996 | EP0699069A1 Endothelin receptor antagonists |
| 03/06/1996 | EP0699068A1 Reduction of liposome-induced adverse physiological reactions |
| 03/06/1996 | EP0479899B1 Vasodilatory and immune suppressant peptides |
| 03/06/1996 | EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method |
| 03/06/1996 | CN1118163A Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 03/06/1996 | CN1117970A Derivative of 5,6-dihydro-4H-thieno|3,4-c¨ pyrrole, preparation and medical application of same |
| 03/06/1996 | CN1117965A Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines |
| 03/06/1996 | CN1117962A Arylbenzoylguanidin |
| 03/06/1996 | CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 03/06/1996 | CN1117874A Nasally administrable compositions |
| 03/05/1996 | US5496832 Method of treating cardiac inflammatory disease |
| 03/05/1996 | US5496814 Steroids for bone disorders and oxidation resistance |
| 03/05/1996 | CA2085733C Polycyclic guanine derivatives |
| 03/02/1996 | CA2157231A1 Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones |
| 03/01/1996 | CA2157156A1 New tetrahydropyranic compounds, process for their preparation and pharmaceutical composition containing them |
| 03/01/1996 | CA2156961A1 Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments |
| 03/01/1996 | CA2156960A1 Arylbenzoylguanidines |
| 03/01/1996 | CA2156959A1 Ortho-substituted benzoic acid derivates |
| 02/29/1996 | WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | WO1996006095A1 Endothelin antagonists |
| 02/29/1996 | WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| 02/29/1996 | WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists |
| 02/29/1996 | WO1996006081A1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 02/29/1996 | WO1996006074A1 Metalloproteinase inhibitors |
| 02/29/1996 | WO1996005839A1 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 02/29/1996 | WO1996005837A1 Use of n-substituted phenothiazines |
| 02/29/1996 | WO1996005827A1 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 02/29/1996 | WO1996005820A1 Hyperlipemia remedy |
| 02/29/1996 | DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other |
| 02/29/1996 | DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines |
| 02/29/1996 | CA2517691A1 Endothelin antagonists |
| 02/29/1996 | CA2198368A1 Hyperlipemia remedy |
| 02/29/1996 | CA2198256A1 Use of n-substituted phenothiazines |
| 02/29/1996 | CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | CA2195973A1 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 02/28/1996 | EP0698616A1 Process for the preparation of a C1-esterase inhibitor (C1-1NH) concentrate and therapeutical use thereof |
| 02/28/1996 | EP0698614A1 Endothelin-antagonizing peptide |
| 02/28/1996 | EP0698609A1 Alpha-phosphorus substituted sulfinate derivatives as squalene synthetase inhibitors |
| 02/28/1996 | EP0698392A1 Compositions containing a RAR alpha specific ligand and at least one fatty acid |
| 02/28/1996 | EP0698391A1 Use of ifenprodil and its diasterisomeren for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative disorders |
| 02/28/1996 | EP0698203A1 Method for selective opening of abnormal brain tissue capillaries |
| 02/28/1996 | EP0698113A1 Production of toxin binding biopolymers, use thereof |
| 02/28/1996 | EP0698039A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
| 02/28/1996 | EP0698031A1 SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION |
| 02/28/1996 | EP0698025A1 Ampa antagonists and a method of treatment therewith |
| 02/28/1996 | EP0698010A1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 02/28/1996 | EP0697886A1 New peptide antagonists at glutamate and nmda receptors |
| 02/28/1996 | EP0697883A1 Use of platelet-derived growth factor to improve collateral circulation |
| 02/28/1996 | EP0697868A1 Methods and compositions using optically pure (+)-zileuton |
| 02/28/1996 | EP0588897B1 Non-chlorofluorocarbon aerosol formulations |
| 02/28/1996 | CN1117712A Extract from flowers of salvia officinalis, process for its preparation and use thereof |
| 02/27/1996 | US5495048 Anticholesterol agents |
| 02/27/1996 | US5495023 Nitro compounds, process for preparation thereof and use thereof |
| 02/27/1996 | US5495022 Antiarrhythmic, isotropic agents |
| 02/27/1996 | US5495013 Process for the preparation of Diltiazem |
| 02/27/1996 | US5494934 Antidepressants, hypotensive agents |
| 02/27/1996 | US5494933 Treatment |
| 02/27/1996 | US5494928 Indole derivatives |
| 02/27/1996 | US5494909 Antiischemic agents |
| 02/27/1996 | US5494907 11-β substituted-19-nor steroids |
| 02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
| 02/27/1996 | CA1338089C Sulfonic acid esters |
| 02/26/1996 | CA2156788A1 Use of 6-amino-1,4-dihydropyridines as medicaments for treatment of the central nervous system, and processes for their preparation |
| 02/26/1996 | CA2156673A1 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments |
| 02/25/1996 | CA2155986A1 .alpha.-phosphonosulfinate squalene synthetase inhibitors and method |
| 02/22/1996 | WO1996005321A1 Gene therapy for restenosis using an adenoviral vector |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996005225A1 Adrenergic receptor |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005190A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
| 02/22/1996 | WO1996005188A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/22/1996 | WO1996005185A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004912A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 02/22/1996 | WO1996004905A1 Phenoxyphenylacetic acid derivatives |